Search for: "Lewis Drugs, Inc."
Results 81 - 100
of 182
Sorted by Relevance
|
Sort by Date
10 Nov 2012, 2:14 pm
THE REEF CONDOMINIUM ASSOCIATION, INC., LEWIS KATZ, JANET HUCKABY, and LANG MANAGEMENT COMPANY, INC., Appellees. 4th District.Civil procedure -- Dismissal -- Service of process -- Timeliness -- Statute of limitations precluding refiling -- Trial court did not abuse its discretion in dismissing action where more than a year had passed without service of complaint or other record activity, and trial court gave full and appropriate consideration to pertinent factors? [read post]
22 Oct 2007, 10:53 am
" Jeannie Lewis-Levett v. [read post]
24 May 2010, 7:46 am
Lewis v. [read post]
23 Mar 2022, 7:21 am
New Relists Lewis v. [read post]
13 Sep 2007, 10:48 am
A lot of doctors discount drug advertising entirely. [read post]
14 Aug 2020, 9:02 am
Lewis v. [read post]
15 Apr 2013, 9:44 am
The “duty of sameness” as a shield—generic drug manufacturers’ tort liability and the need for label independence after … (PLIVA, Inc. v. [read post]
29 Apr 2009, 2:06 am
Goodman"), and Pfizer Inc ("Pfizer"). [read post]
22 May 2011, 12:00 pm
In this case, SOCA brought civil recovery proceedings against the Appellants under Part 5 Proceeds of Crime Act 2002 to recover assets that it alleges were derived from drug trafficking, money laundering and tax evasion notwithstanding that in criminal proceedings against the First Appellant for alleged involvement in drug trafficking, the Spanish proceedings were discontinued and he was acquitted in Portugal. [read post]
13 Jun 2011, 3:33 am
Tomco Machining, Inc. [read post]
25 Oct 2021, 1:31 pm
Huey Lewis and the News, “I Want A New Drug” (1984) Ray Parker Jr., “Ghostbusters” (1984)2. [read post]
11 Jan 2017, 7:19 am
Sandoz Inc. v. [read post]
11 Feb 2011, 7:51 am
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
30 May 2012, 1:37 pm
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
22 Jun 2011, 7:09 am
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
2 Oct 2010, 8:43 am
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
15 Feb 2012, 7:42 am
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
14 Sep 2011, 12:08 pm
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
14 Sep 2011, 12:07 pm
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
9 Sep 2011, 8:40 am
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
